Annual Revenue
$81.00 M
-$26.40 M-24.58%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual revenue is $81.00 million, with the most recent change of -$26.40 million (-24.58%) on June 30, 2024.
- During the last 3 years, AYTU annual revenue has risen by +$15.37 million (+23.42%).
- AYTU annual revenue is now -24.58% below its all-time high of $107.40 million, reached on June 30, 2023.
Performance
AYTU Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$16.57 M
-$1.40 M-7.80%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly revenue is $16.57 million, with the most recent change of -$1.40 million (-7.80%) on September 30, 2024.
- Over the past year, AYTU quarterly revenue has dropped by -$1.24 million (-6.98%).
- AYTU quarterly revenue is now -46.07% below its all-time high of $30.73 million, reached on June 30, 2023.
Performance
AYTU Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$75.48 M
-$1.24 M-1.62%
September 30, 2024
Summary
- As of February 8, 2025, AYTU TTM revenue is $75.48 million, with the most recent change of -$1.24 million (-1.62%) on September 30, 2024.
- Over the past year, AYTU TTM revenue has dropped by -$22.08 million (-22.64%).
- AYTU TTM revenue is now -29.72% below its all-time high of $107.40 million, reached on June 30, 2023.
Performance
AYTU TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
AYTU Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.6% | -7.0% | -22.6% |
| 3 y3 years | +23.4% | -24.3% | +2.0% |
| 5 y5 years | +1006.5% | +22.9% | +32.4% |
AYTU Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | +23.4% | -46.1% | at low | -29.7% | at low |
| 5 y | 5-year | -24.6% | +1006.5% | -46.1% | +422.0% | -29.7% | +766.7% |
| alltime | all time | -24.6% | >+9999.0% | -46.1% | >+9999.0% | -29.7% | >+9999.0% |
Aytu BioPharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $16.57 M(-7.8%) | $75.48 M(-1.6%) |
| Jun 2024 | $81.00 M(-24.6%) | $17.98 M(-0.1%) | $76.72 M(-14.3%) |
| Mar 2024 | - | $17.99 M(-21.5%) | $89.48 M(-5.0%) |
| Dec 2023 | - | $22.93 M(+28.7%) | $94.22 M(-3.4%) |
| Sep 2023 | - | $17.82 M(-42.0%) | $97.56 M(-9.2%) |
| Jun 2023 | $107.40 M(+11.1%) | $30.73 M(+35.2%) | $107.40 M(+3.2%) |
| Mar 2023 | - | $22.73 M(-13.5%) | $104.11 M(-1.4%) |
| Dec 2022 | - | $26.28 M(-5.0%) | $105.58 M(+3.1%) |
| Sep 2022 | - | $27.66 M(+0.8%) | $102.43 M(+6.0%) |
| Jun 2022 | $96.67 M(+47.3%) | $27.45 M(+13.4%) | $96.67 M(+4.3%) |
| Mar 2022 | - | $24.20 M(+4.6%) | $92.70 M(+13.1%) |
| Dec 2021 | - | $23.13 M(+5.6%) | $81.99 M(+10.8%) |
| Sep 2021 | - | $21.90 M(-6.7%) | $74.01 M(+12.8%) |
| Jun 2021 | $65.63 M(+137.5%) | $23.48 M(+74.2%) | $65.63 M(+15.1%) |
| Mar 2021 | - | $13.48 M(-11.0%) | $57.01 M(+10.3%) |
| Dec 2020 | - | $15.15 M(+12.0%) | $51.68 M(+30.1%) |
| Sep 2020 | - | $13.52 M(-9.0%) | $39.71 M(+43.7%) |
| Jun 2020 | $27.63 M(+277.5%) | $14.86 M(+82.2%) | $27.63 M(+90.7%) |
| Mar 2020 | - | $8.16 M(+156.9%) | $14.49 M(+66.4%) |
| Dec 2019 | - | $3.18 M(+120.5%) | $8.71 M(+18.8%) |
| Sep 2019 | - | $1.44 M(-16.1%) | $7.33 M(+0.1%) |
| Jun 2019 | $7.32 M | $1.72 M(-27.8%) | $7.32 M(+12.1%) |
| Mar 2019 | - | $2.38 M(+32.5%) | $6.53 M(+37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | - | $1.79 M(+25.4%) | $4.76 M(+18.5%) |
| Sep 2018 | - | $1.43 M(+54.8%) | $4.01 M(+9.7%) |
| Jun 2018 | $3.66 M(+13.6%) | $925.10 K(+52.4%) | $3.66 M(+2.5%) |
| Mar 2018 | - | $607.00 K(-42.2%) | $3.57 M(-7.4%) |
| Dec 2017 | - | $1.05 M(-2.3%) | $3.86 M(+7.1%) |
| Sep 2017 | - | $1.08 M(+28.7%) | $3.60 M(+11.7%) |
| Jun 2017 | $3.22 M(+25.7%) | $836.00 K(-6.5%) | $3.22 M(-3.0%) |
| Mar 2017 | - | $894.00 K(+12.6%) | $3.32 M(+7.3%) |
| Dec 2016 | - | $794.00 K(+13.8%) | $3.10 M(+11.7%) |
| Sep 2016 | - | $698.00 K(-25.5%) | $2.77 M(+8.2%) |
| Jun 2016 | $2.56 M(+878.8%) | $937.30 K(+40.2%) | $2.56 M(+41.8%) |
| Mar 2016 | - | $668.40 K(+42.4%) | $1.81 M(+55.4%) |
| Dec 2015 | - | $469.40 K(-3.7%) | $1.16 M(+67.7%) |
| Sep 2015 | - | $487.40 K(+167.8%) | $693.20 K(+236.8%) |
| Jun 2015 | $261.80 K(>+9900.0%) | $182.00 K(+664.7%) | $205.80 K(+729.8%) |
| Mar 2015 | - | $23.80 K(+2280.0%) | $24.80 K(+2380.0%) |
| Aug 2014 | $1000.00(-98.3%) | - | - |
| Jun 2014 | $58.90 K(+3172.2%) | - | - |
| May 2014 | - | $1000.00(-44.4%) | $1000.00(-72.2%) |
| Aug 2013 | $1800.00(0.0%) | - | - |
| May 2013 | - | $1800.00(0.0%) | $3600.00(+100.0%) |
| Aug 2012 | $1800.00(0.0%) | $1800.00(0.0%) | $1800.00(0.0%) |
| Aug 2009 | $1800.00 | - | - |
| May 2009 | - | $1800.00 | $1800.00 |
FAQ
- What is Aytu BioPharma annual revenue?
- What is the all time high annual revenue for Aytu BioPharma?
- What is Aytu BioPharma annual revenue year-on-year change?
- What is Aytu BioPharma quarterly revenue?
- What is the all time high quarterly revenue for Aytu BioPharma?
- What is Aytu BioPharma quarterly revenue year-on-year change?
- What is Aytu BioPharma TTM revenue?
- What is the all time high TTM revenue for Aytu BioPharma?
- What is Aytu BioPharma TTM revenue year-on-year change?
What is Aytu BioPharma annual revenue?
The current annual revenue of AYTU is $81.00 M
What is the all time high annual revenue for Aytu BioPharma?
Aytu BioPharma all-time high annual revenue is $107.40 M
What is Aytu BioPharma annual revenue year-on-year change?
Over the past year, AYTU annual revenue has changed by -$26.40 M (-24.58%)
What is Aytu BioPharma quarterly revenue?
The current quarterly revenue of AYTU is $16.57 M
What is the all time high quarterly revenue for Aytu BioPharma?
Aytu BioPharma all-time high quarterly revenue is $30.73 M
What is Aytu BioPharma quarterly revenue year-on-year change?
Over the past year, AYTU quarterly revenue has changed by -$1.24 M (-6.98%)
What is Aytu BioPharma TTM revenue?
The current TTM revenue of AYTU is $75.48 M
What is the all time high TTM revenue for Aytu BioPharma?
Aytu BioPharma all-time high TTM revenue is $107.40 M
What is Aytu BioPharma TTM revenue year-on-year change?
Over the past year, AYTU TTM revenue has changed by -$22.08 M (-22.64%)